Photo of a final puzzle piece about to fit into a puzzle
Biotech

Novo inks $600M NanoVation deal to study genetic drugs ex-liver

Novo Nordisk agreed to pay NanoVation up to $600 million to collaborate on programs built on technology for targeting cells outside the liver.
Nick Paul Taylor Sep 18, 2024 9:03am
Avacare

Beyond data: Humanizing clinical research with Avacare

Sep 16, 2024 9:00am
Medtronic headquarters

Medtronic details study of adaptive neurostim in Parkinson’s

Sep 18, 2024 12:15pm
Alzheimers PET scans

GE HealthCare claims FDA clearance for amyloid imaging software

Sep 18, 2024 11:00am
Colon cancer

ESMO: Innovent links cytokine to colorectal cancer responses

Sep 18, 2024 9:53am
FDA

FDA scraps adcomm for Applied's rare disease drug

Sep 18, 2024 8:00am
Medtech News

FDA elevates recall as Zimmer Biomet phases out hip implant

Sep 17, 2024 2:40pm

FDA clears Senseonics’ 365-day Eversense CGM implant

Sep 17, 2024 11:00am

Rakovina deepens AI focus with collab to select cancer targets

Sep 17, 2024 9:20am

Exact Sciences presents early colorectal cancer blood test data

Sep 16, 2024 11:30am